Health status of prevalent cancer cases as measured by mortality dynamics (cancer vs. noncancer): Application to five major cancers sites

Background Cancer prevalence is heterogeneous because it includes individuals who are undergoing initial treatment and those who are in remission, experiencing relapse, or cured. The proposed statistical approach describes the health status of this group by estimating the probabilities of death amon...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 2022-10, Vol.128 (20), p.3663-3673
Main Authors: Colonna, Marc, Grosclaude, Pascale, Bouvier, Anne Marie, Goungounga, Juste, Jooste, Valérie
Format: Article
Language:English
Subjects:
Breast cancer
Breast Neoplasms
Cause of Death
causes of death
Colorectal cancer
Colorectal carcinoma
crude probability of death
Death
Diagnosis
excess mortality rate
Fatalities
Female
Health Status
Humans
Incidence
Lung cancer
Lung Neoplasms - epidemiology
Male
Melanoma
Mortality
Neoplasm Recurrence, Local
Neoplasms
Oncology
Patients
Prevalence
Probability
Prostate cancer
Remission
Statistical analysis
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Cancer prevalence is heterogeneous because it includes individuals who are undergoing initial treatment and those who are in remission, experiencing relapse, or cured. The proposed statistical approach describes the health status of this group by estimating the probabilities of death among prevalent cases. The application concerns colorectal, lung, breast, and prostate cancers and melanoma in France in 2017. Methods Excess mortality was used to estimate the probabilities of death from cancer and other causes. Results For the studied cancers, most deaths from cancer occurred during the first 5 years after diagnosis. The probability of death from cancer decreased with increasing time since diagnosis except for breast cancer, for which it remained relatively stable. The time beyond which the probability of death from cancer became lower than that from other causes depended on age and cancer site: for colorectal cancer, it was 6 years after diagnosis for women (7 years for men) aged 75–84 and 20 years for women (18 years for men) aged 45–54 years, whereas cancer was the major cause of death for women younger than 75 years whatever the time since diagnosis for breast and for all patients younger than 75 years for lung cancer. In contrast, deaths from other causes were more frequent in all the patients older than 75 years. Apart from breast cancer in women younger than 55 years and lung cancer in women older than 55 years and men older than 65 years, the probability of death from cancer among prevalent cases fell below 1%, with varying times since diagnosis. Conclusions The authors' approach can be used to better describe the burden of cancer by estimating outcomes in prevalent cases. Cancer prevalence covers a population whose health status is heterogeneous. A statistical approach that combined prevalence and crude probabilities of death was used to demonstrate that the distribution of prevalent cases regarding the risk of death according to causes varied by cancer site, time since diagnosis, and age.
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.34413